Cleveland Biolabs Inc (CBLI.OQ)

CBLI.OQ on NASDAQ Stock Exchange Capital Market

0.38USD
26 Nov 2014
Price Change (% chg)

$-0.00 (-1.32%)
Prev Close
$0.38
Open
$0.38
Day's High
$0.38
Day's Low
$0.37
Volume
7,860
Avg. Vol
46,130
52-wk High
$1.40
52-wk Low
$0.34

CBLI.OQ

Chart for CBLI.OQ

About

Cleveland BioLabs, Inc. is a clinical-stage biotechnology company with a focus on oncology drug development. The Company’s lead drug candidate CBLB502 is developed for dual indications under the United States Food & Drug Administration's (FDA's) Animal Efficacy Rule, commonly referred to as the Animal Rule, as a radiation... (more)
No analyst recommendations are available for CBLI.OQ.

Overall

Beta: 1.65
Market Cap (Mil.): $21.48
Shares Outstanding (Mil.): 57.15
Dividend: --
Yield (%): --

Financials

  CBLI.OQ Industry Sector
P/E (TTM): -- 219.87 38.74
EPS (TTM): -0.19 -- --
ROI: -- -2.35 17.27
ROE: -- -3.55 18.18
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: New Constructs, LLC
$25.00
Provider: Pechala's Reports
$25.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00
Provider: Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks